Advertisement

Role of Microorganisms in Degradation and Removal of Anticonvulsant Drugs: A Review

  • Neha Alok SinhaEmail author
  • Vipin Kumar
Chapter
  • 301 Downloads
Part of the Energy, Environment, and Sustainability book series (ENENSU)

Abstract

Over the past few years, large amounts of pharmaceutical compounds along with their active metabolites are emerging as environmental pollutants, which enters into water systems from different sources, such as sewage (human and animal excretion), landfill sites, wastewater from pharmaceutical industries and hospitals. In recent years the wide use of anticonvulsant drugs is one of the environmental concern due to its frequent use and determination in the environment. Anticonvulsant drugs and their metabolites are present in trace concentrations of µg L−1 to mg L−1 in water bodies. Biodegradation of these drug depends upon the different factors, such as physicochemical properties of drug, environmental factors (i.e. pH, light, temperature) and type of microbial strain. Different microbes like fungal strains (Cunninghamella elegans ATCC 9245, Umbelopsis ramanniana R-56) and Bacillus and Streptomyces species of bacteria have been reported with the ability to degrade pharmaceutical compounds via metabolic and metabolic pathways. This chapter summarizes the knowledge about biotransformation or biodegradation of anticonvulsant drugs and their metabolic pathways.

Keywords

Biodegradation Anticonvulsant drugs Microorganisms Metabolic pathways 

Notes

Acknowledgements

The authors thank the financial support from Indian Institute of Technology (Indian School of Mines), Dhanbad under Junior Research Fellowship scheme funded by Ministry of Human Resource Development (MHRD).

References

  1. Atalay S, Ersöz G (2016) Novel catalysts in advanced oxidation of organic pollutants. Springer International PublishingGoogle Scholar
  2. Aukema KG, Escalante DE, Maltby MM, Bera AK, Aksan A, Wackett LP (2016) In silico identification of bioremediation potential: carbamazepine and other recalcitrant personal care products. Environ Sci Technol 51(2):880–888CrossRefGoogle Scholar
  3. Bahr C, Schumacher J, Ernst M, Luck F, Heinzmann B, Jekel M (2007) SUVA as control parameter for the effective ozonation of organic pollutants in secondary effluent. Water Sci Technol 55(12):267–274CrossRefGoogle Scholar
  4. Barbosa MO, Moreira NF, Ribeiro AR, Pereira MF, Silva AM (2016) Occurrence and removal of organic micropollutants: an overview of the watch list of EU Decision 2015/495. Water Res 94:257–279CrossRefGoogle Scholar
  5. Bottoni P, Caroli S, Caracciolo AB (2010) Pharmaceuticals as priority water contaminants. Toxicol Environ Chem 92(3):549–565CrossRefGoogle Scholar
  6. Bouju H, Ricken B, Beffa T, Corvini PFX, Kolvenbach BA (2012) Isolation of bacterial strains capable of sulfamethoxazole mineralization from an acclimated membrane bioreactor. Appl Environ Microbiol 78(1):277–279CrossRefGoogle Scholar
  7. Boxall AB (2004) The environmental side effects of medication: how are human and veterinary medicines in soils and water bodies affecting human and environmental health? EMBO Rep 5(12):1110–1116CrossRefGoogle Scholar
  8. Brozinski JM, Lahti M, Meierjohann A, Oikari A, Kronberg L (2012) The anti-inflammatory drugs diclofenac, naproxen and ibuprofen are found in the bile of wild fish caught downstream of a wastewater treatment plant. Environ Sci Technol 47(1):342–348CrossRefGoogle Scholar
  9. Buchicchio A, Bianco G, Sofo A, Masi S, Caniani D (2016) Biodegradation of carbamazepine and clarithromycin by Trichoderma harzianum and Pleurotus ostreatus investigated by liquid chromatography–high-resolution tandem mass spectrometry (FTICR MS-IRMPD). Sci Total Environ 557:733–739CrossRefGoogle Scholar
  10. Caracciolo AB, Topp E, Grenni P (2015) Pharmaceuticals in the environment: biodegradation and effects on natural microbial communities. A review. J Pharm Biomed Anal 106:25–36CrossRefGoogle Scholar
  11. Castiglioni S, Zuccato E, Crisci E, Chiabrando C, Fanelli R, Bagnati R (2006) Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography—tandem mass spectrometry. Anal Chem 78(24):8421–8429CrossRefGoogle Scholar
  12. Chen J, Xie S (2018) Overview of sulfonamide biodegradation and the relevant pathways and microorganisms. Sci Total Environ 640:1465–1477CrossRefGoogle Scholar
  13. Cordy GE, Duran NL, Bouwer H, Rice RC, Furlong ET, Zaugg SD, Meyer MT, Barber LB, Kolpin DW (2004) Do pharmaceuticals, pathogens, and other organic waste water compounds persist when waste water is used for recharge? Groundwater Monit Rem 24(2):58–69CrossRefGoogle Scholar
  14. Cribb AE, Spielberg SP (1992) Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther 51(5):522–526CrossRefGoogle Scholar
  15. Drillia P, Dokianakis SN, Fountoulakis MS, Kornaros M, Stamatelatou K, Lyberatos G (2005) On the occasional biodegradation of pharmaceuticals in the activated sludge process: the example of the antibiotic sulfamethoxazole. J Hazard Mater 122(3):259–265CrossRefGoogle Scholar
  16. Emke E, Evans S, Kasprzyk-Hordern B, de Voogt P (2014) Enantiomer profiling of high loads of amphetamine and MDMA in communal sewage: a Dutch perspective. Sci Total Environ 487:666–672CrossRefGoogle Scholar
  17. Escher BI, Baumgartner R, Koller M, Treyer K, Lienert J, McArdell CS (2011) Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 45(1):75–92CrossRefGoogle Scholar
  18. Evgenidou EN, Konstantinou IK, Lambropoulou DA (2015) Occurrence and removal of transformation products of PPCPs and illicit drugs in wastewaters: a review. Sci Total Environ 505:905–926CrossRefGoogle Scholar
  19. Fent K, Weston AA, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76(2):122–159CrossRefGoogle Scholar
  20. Goldenberg MM (2010) Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. Pharm Ther 35(7):392Google Scholar
  21. Ha H, Mahanty B, Yoon S, Kim CG (2016) Degradation of the long-resistant pharmaceutical compounds carbamazepine and diatrizoate using mixed microbial culture. J Environ Sci Health Part A 51(6):467–471CrossRefGoogle Scholar
  22. Herzog B, Lemmer H, Horn H, Müller E (2013) Characterization of pure cultures isolated from sulfamethoxazole-acclimated activated sludge with respect to taxonomic identification and sulfamethoxazole biodegradation potential. BMC Microbiol 13(1):276CrossRefGoogle Scholar
  23. Höltge S, Kreuzig R (2007) Laboratory testing of sulfamethoxazole and its metabolite acetyl‐sulfamethoxazole in soil. CLEAN–Soil Air Water 35(1):104–110CrossRefGoogle Scholar
  24. Huang M, Tian S, Chen D, Zhang W, Wu J, Chen L (2012) Removal of sulfamethazine antibiotics by aerobic sludge and an isolated Achromobacter sp. S-3. J Environ Sci 24(9):1594–1599CrossRefGoogle Scholar
  25. Illés E, Szabó E, Takács E, Wojnárovits L, Dombi A, Gajda-Schrantz K (2014) Ketoprofen removal by O3 and O3/UV processes: kinetics, transformation products, and ecotoxicity. Sci Total Environ 472:178–184CrossRefGoogle Scholar
  26. Jelic A, Gros M, Ginebreda A, Cespedes-Sánchez R, Ventura F, Petrovic M, Barcelo D (2011) Occurrence, partition, and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res 45(3):1165–1176CrossRefGoogle Scholar
  27. Jiang J, Zhou Z (2013) Removal of pharmaceutical residues by ferrate (VI). PLoS ONE 8(2):e55729CrossRefGoogle Scholar
  28. Jiang B, Li A, Cui D, Cai R, Ma F, Wang Y (2014) Biodegradation and metabolic pathway of sulfamethoxazole by Pseudomonas psychrophila HA-4, a newly isolated cold-adapted sulfamethoxazole-degrading bacterium. Appl Microbiol Biotechnol 98(10):4671–4681CrossRefGoogle Scholar
  29. Kang SI, Kang SY, Hur HG (2008) Identification of fungal metabolites of anticonvulsant drug carbamazepine. Appl Microbiol Biotechnol 79(4):663CrossRefGoogle Scholar
  30. Khetan SK, Collins TJ (2007) Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem Rev 107(6):2319–2364CrossRefGoogle Scholar
  31. Kittelmann M, Lattmann R, Ghisalba O (1993) Preparation of 10, 11-epoxy-carbamazepine and 10, 11-dihydro-10-hydroxy-carbamazepine by microbial epoxidation and hydroxylation. Biosci Biotechnol Biochem 57(9):1589–1590CrossRefGoogle Scholar
  32. Kümmerer K (2009) The presence of pharmaceuticals in the environment due to human use–present knowledge and future challenges. J Environ Manage 90(8):2354–2366CrossRefGoogle Scholar
  33. Lertratanangkoon K, Horning MG (1982) Metabolismof carbamazepine. Drug Metab Dispos 10:1–10Google Scholar
  34. Li A, Cai R, Cui D, Qiu T, Pang C, Yang J, Ren N (2013) Characterization and biodegradation kinetics of a new cold-adapted carbamazepine-degrading bacterium, Pseudomonas sp. CBZ-4. J Environ Sci 25(11):2281–2290CrossRefGoogle Scholar
  35. Li X, Xu J, de Toledo RA, Shim H (2016) Enhanced carbamazepine removal by immobilized Phanerochaete chrysosporium in a novel rotating suspension cartridge reactor under non-sterile condition. Int Biodeterior Biodegradation 115:102–109CrossRefGoogle Scholar
  36. Loos R, Locoro G, Comero S, Contini S, Schwesig D, Werres F, Balsaa P, Gans O, Weiss S, Blaha L, Bolchi M (2010) Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Res 44(14):4115–4126CrossRefGoogle Scholar
  37. Mao F, Liu X, Wu K, Zhou C, Si Y (2018) Biodegradation of sulfonamides by Shewanella oneidensis MR-1 and Shewanella sp. strain MR-4. Biodegradation 29(2):129–140CrossRefGoogle Scholar
  38. Marco-Urrea E, Pérez-Trujillo M, Vicent T, Caminal G (2009) Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor. Chemosphere 74(6):765–772CrossRefGoogle Scholar
  39. Michael I, Rizzo L, McArdell CS, Manaia CM, Merlin C, Schwartz T, Dagot C, Fatta-Kassinos D (2013) Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: a review. Water Res 47(3):957–995CrossRefGoogle Scholar
  40. Monteiro SC, Boxall AB (2010) Occurrence and fate of human pharmaceuticals in the environment. Reviews of environmental contamination and toxicology. Springer, New York, NY, pp 53–154CrossRefGoogle Scholar
  41. Mulla SI, Sun Q, Hu A, Wang Y, Ashfaq M, Eqani SAMAS, Yu CP (2016) Evaluation of sulfadiazine degradation in three newly isolated pure bacterial cultures. PLoS ONE 11(10):e0165013CrossRefGoogle Scholar
  42. Muñoz I, Bueno MJM, Agüera A, Fernández-Alba AR (2010) Environmental and human health risk assessment of organic micro-pollutants occurring in a Spanish marine fish farm. Environ Pollut 158(5):1809–1816CrossRefGoogle Scholar
  43. Nguyen PY, Carvalho G, Reis AC, Nunes OC, Reis MAM, Oehmen A (2017) Impact of biogenic substrates on sulfamethoxazole biodegradation kinetics by Achromobacter denitrificans strain PR1. Biodegradation 28(2–3):205–217CrossRefGoogle Scholar
  44. Ottmar KJ, Colosi LM, Smith JA (2010) Development and application of a model to estimate wastewater treatment plant prescription pharmaceutical influent loadings and concentrations. Bull Environ Contam Toxicol 84(5):507–512CrossRefGoogle Scholar
  45. Ozdemir G, Aydin E, Topuz E, Yangin-Gomec C, Tas DO (2015) Acute and chronic responses of denitrifying culture to diclofenac. Biores Technol 176:112–120CrossRefGoogle Scholar
  46. Pan LJ, Li CX, Yu GW, Wang Y (2017) Biodegradation of sulfamethazine by an isolated thermophile–Geobacillus sp. S-07. World J Microbiol Biotechnol 33(5):85Google Scholar
  47. Radke M, Ulrich H, Wurm C, Kunkel U (2010) Dynamics and attenuation of acidic pharmaceuticals along a river stretch. Environ Sci Technol 44(8):2968–2974CrossRefGoogle Scholar
  48. Reis PJ, Reis AC, Ricken B, Kolvenbach BA, Manaia CM, Corvini PF, Nunes OC (2014) Biodegradation of sulfamethoxazole and other sulfonamides by Achromobacter denitrificans PR1. J Hazard Mater 280:741–749CrossRefGoogle Scholar
  49. Ricken B, Corvini PF, Cichocka D, Parisi M, Lenz M, Wyss D, Kohler HPE (2013) Ipso-hydroxylation and subsequent fragmentation: a novel microbial strategy to eliminate sulfonamide antibiotics. Appl Environ Microbiol 79(18):5550–5558CrossRefGoogle Scholar
  50. Rodarte-Morales AI, Feijoo G, Moreira MT, Lema JM (2012) Biotransformation of three pharmaceutical active compounds by the fungus Phanerochaete chrysosporium in a fed batch stirred reactor under air and oxygen supply. Biodegradation 23(1):145–156CrossRefGoogle Scholar
  51. Shoaib Ahmad Shah S, Rivera G, Ashfaq M (2013) Recent advances in medicinal chemistry of sulfonamides. Rational design as anti-tumoral, anti-bacterial and anti-inflammatory agents. Mini Rev Med Chem 13(1):70–86CrossRefGoogle Scholar
  52. Sutton NB, Langenhoff AA, Lasso DH, van der Zaan B, van Gaans P, Maphosa F, Rijnaarts HH (2014) Recovery of microbial diversity and activity during bioremediation following chemical oxidation of diesel contaminated soils. Appl Microbiol Biotechnol 98(6):2751–2764CrossRefGoogle Scholar
  53. Tanna RN, Tetreault GR, Bennett CJ, Smith BM, Bragg LM, Oakes KD, McMaster ME, Servos MR (2013) Occurrence and degree of intersex (testis–ova) in darters (Etheostoma SPP.) across an urban gradient in the Grand River, Ontario, Canada. Environ Toxicol Chem 32(9):1981–1991CrossRefGoogle Scholar
  54. Tappe W, Hofmann D, Disko U, Koeppchen S, Kummer S, Vereecken H (2015) A novel isolated Terrabacter-like bacterium can mineralize 2-aminopyrimidine, the principal metabolite of microbial sulfadiazine degradation. Biodegradation 26(2):139–150CrossRefGoogle Scholar
  55. Tiwari B, Sellamuthu B, Ouarda Y, Drogui P, Tyagi RD, Buelna G (2017) Review on fate and mechanism of removal of pharmaceutical pollutants from wastewater using a biological approach. Biores Technol 224:1–12CrossRefGoogle Scholar
  56. Topp E, Chapman R, Devers-Lamrani M, Hartmann A, Marti R, Martin-Laurent F, Sumarah M (2013) Accelerated biodegradation of veterinary antibiotics in agricultural soil following long-term exposure, and isolation of a sulfamethazine-degrading Microbacterium sp. J Environ Qual 42(1):173–178CrossRefGoogle Scholar
  57. Wang S, Wang J (2018) Biodegradation and metabolic pathway of sulfamethoxazole by a novel strain Acinetobacter sp. Appl Microbiol Biotechnol 102(1):425–432CrossRefGoogle Scholar
  58. Yang CW, Hsiao WC, Chang BV (2016) Biodegradation of sulfonamide antibiotics in sludge. Chemosphere 150:559–565CrossRefGoogle Scholar
  59. Zhang W, Zhang M, Lin K, Sun W, Xiong B, Guo M, Cui X, Fu R (2012) Eco-toxicological effect of Carbamazepine on Scenedesmus obliquus and Chlorella pyrenoidosa. Environ Toxicol Pharmacol 33(2):344–352CrossRefGoogle Scholar
  60. Zimmerman MJ (2005) Occurrence of organic wastewater contaminants, pharmaceuticals, and personal care products in selected water supplies, Cape Cod, Massachusetts, June 2004 (No. USGS-OFR-2005–1206). GEOLOGICAL SURVEY RESTON VAGoogle Scholar
  61. Zuccato E, Castiglioni S, Fanelli R (2005) Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J Hazard Mater 122(3):205–209CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Department of Environmental Science and EngineeringIndian Institute of Technology (Indian School of Mines)DhanbadIndia

Personalised recommendations